Neonatal Care

Consumer input: Use of erythropoietin (EPO) for treating hypoxic-ischaemic encephalopathy in newborn babies

Skills / interests: Consumer (public, patient, carer) input

Hypoxic-ischaemic encephalopathy (HIE) is brain damage caused by low oxygen and low blood supply in the brain at birth. It can cause infant death or a range of developmental delay and disability. Erythropoietin (EPO) is a hormone that regulates red blood cell development and maturation, and synthetic forms are widely used to prevent or treat anaemia.

We have two reviews looking at whether EPO can be used to treat HIE in newborns - one review looking at very premature babies, another in babies who are either full term, or only slightly premature. We ARE looking for consumer input into these reviews - please do get in touch if you have an interest in either one or both of these reviews.

Erythropoietin for preterm infants with hypoxic-ischaemic encephalopathy

Erythropoietin for term and late preterm infants with hypoxic-ischaemic encephalopathy

Think you've got what it takes to get the job done for Anne-Marie?

Log in
to respond

Questions & comments